OakChart

Virtus Biotech Clinical Trials ETF

BBCFinancial·Exchange Traded Fund·USA·NYSE·Nov 10 • 3:59 PM ET

44.880.00 (0.00%)
2026-11-11 15:15 CET
Market cap
- USD m
Revenue, TTM
- USD m
Net income, TTM
- USD m
Free cash flow, TTM
- USD m
EPS diluted, TTM
-
P/E
-
Compare

Price

BBC against its 20, 50 and 200-day averages
2050200
35.0040.0045.0050.0055.00111K221KMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BBCclose 44.8820-day 42.3150-day 45.50200-day 45.6844.88

20.1% under 56.18 on 19 Aug 2026. Last 15 sessions, 11.5% high to low

Profile

BBC

Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

News

latest 14 of 206
  • What's Going On With Alumis Stock Thursday? (Benzinga)
  • Can ETF Winners of Q4 of 2025 Rally in Q1 of 2026? (Zacks)
  • Biotech ETF (BBC) Hits New 52-Week High (Zacks)
  • The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI (Zacks)
  • Best-Performing ETFs of Last Week: Healthcare Rules (Zacks)
  • Loading…
  • Best-Performing ETFs of Last Week (Zacks)
  • Biotech ETFs Hovering Around a 52-Week: Here's Why (Zacks)
  • Biotech ETF (BBC) Hits New 52-Week High (Zacks)
  • Biotech ETFs Bounce Back in 2025: Here's Why (Zacks)
  • Trade War or Not, Specific Industry ETFs Are in Sweet Spots (Zacks)
  • The Zacks Analyst Blog Highlights BWET, GOEX, SLVP, LIT and BBC (Zacks)
  • Best-Performing ETFs of Last Week (Zacks)
  • Aim To Keep Risk Modest And Quality High (Seeking Alpha)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
No quarterly earnings.

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
No annual earnings.

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

No estimate history.

Income statement, annual

No statement data.

Income statement, quarterly

No statement data.

Balance sheet, annual

No statement data.

Cash flow, annual

No statement data.

Balance sheet, quarterly

No statement data.

Cash flow, quarterly

No statement data.

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-30-0.1M-23.41K
2026-10-15-0.1M-20.14K
2026-09-30-0.1M-21.31K
2026-09-15-0.1M-22.73K
2026-08-31-0.1M-22.88K
2026-08-14-0.1M-24.71K
2026-07-31-0.1M-27.03K
2026-07-15-0.1M-27.66K
2026-06-30-0.1M-24.25K
2026-06-15-0.0M-21.97K
2026-05-29-0.1M-22.85K
2026-05-15-0.1M-20.40K
2026-04-30-0.1M-19.92K
2026-04-15-0.1M-19.58K
2026-03-31-0.0M-22.81K
2026-03-13-0.0M-24.27K
2026-02-27-0.0M-27.33K
2026-02-13-0.0M-28.65K
2026-01-30-0.0M-26.88K
2026-01-15-0.0M-26.47K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call37.000.000.000.00-0.000.00---
call38.000.000.000.00-0.000.00---
call39.000.000.000.00-0.000.00---
call40.000.000.003.85-15.000.00---
call41.000.000.000.00-0.000.00---
call42.000.000.000.00-0.000.00---
call43.000.000.000.80-7.000.00---
call44.000.000.000.75-1.000.00---
call45.000.000.000.00-0.000.00---
call46.000.000.000.65-1.000.00---
call47.000.000.000.00-0.000.00---
call48.000.000.000.35-2.000.00---
call49.000.000.000.20-4.000.00---
call50.000.000.000.00-0.000.00---
call51.000.000.000.00-0.000.00---
call52.000.000.000.00-0.000.00---
call53.000.000.000.00-0.000.00---
call54.000.000.000.00-0.000.00---
call55.000.000.000.00-0.000.00---
call56.000.000.000.00-0.000.00---
call57.000.000.000.00-0.000.00---
call58.000.000.000.00-0.000.00---
put37.000.000.000.00-0.000.00---
put38.000.000.000.00-0.000.00---
put39.000.000.000.00-0.000.00---
put40.000.000.001.18-1.000.00---
put41.000.000.000.00-0.000.00---
put42.000.000.000.00-0.000.00---
put43.000.000.000.85-1.000.00---
put44.000.000.000.00-0.000.00---
put45.000.000.002.71-1.000.00---
put46.000.000.000.00-0.000.00---
put47.000.000.000.00-0.000.00---
put48.000.000.000.00-0.000.00---
put49.000.000.000.00-0.000.00---
put50.000.000.000.00-0.000.00---
put51.000.000.000.00-0.000.00---
put52.000.000.000.00-0.000.00---
put53.000.000.000.00-0.000.00---
put54.000.000.000.00-0.000.00---
put55.000.000.000.00-0.000.00---
put56.000.000.000.00-0.000.00---
put57.000.000.000.00-0.000.00---
put58.000.000.000.00-0.000.00---

Latest SEC filings

0
FiledFormDescriptionPeriodLink
No filings.

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Kera Capital Partners, Inc.10.63%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC7.97%
Militia Capital Management LLC4.81%
CITADEL ADVISORS LLC4.50%
SUSQUEHANNA INTERNATIONAL GROUP, LLP4.10%
Quantinno Capital Management LP2.42%
MORGAN STANLEY1.58%
LPL Financial LLC1.07%
GOLDMAN SACHS GROUP INC0.91%
OSAIC HOLDINGS, INC.0.47%

Funds

Fund% owned
-

OakChart. BBC. Cached 15 minutes.

Some panels did not load: snapshot, ratings, insider, lf.